Lv51
1370 积分 2022-07-07 加入
Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer
22分钟前
已完结
Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer
57分钟前
已完结
MNK, mTOR or eIF4E-selecting the best anti-tumor target for blocking translation initiation
59分钟前
已完结
TSC2 loss in neural progenitor cells suppresses mRNA translation of neurodevelopmental genes
1小时前
已完结
Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition
1小时前
已完结
Update on the Development of MNK Inhibitors as Therapeutic Agents
1小时前
已完结
Progress in developing MNK inhibitors
1小时前
已完结
Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors
1小时前
已完结
Mnk Inhibitors: a Patent Review
2小时前
已完结
Discovery of Potent and Selective MNK Kinase Inhibitors for the Treatment of Leukemia
2小时前
已完结
皖公网安备34019202002308
